James Lu is listed as a director on 1 SEC Form D filing by 1 issuer in Oct 2023: Window Therapeutics, Inc. (Boston, MA — biotechnology — 2023; $7.55M reported sold to 10 investors).
What this means One deal on file with the SEC, filed Oct 2023. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Chih-Kao Hu (1 shared filing), Jeremiah Johnson (1 shared filing), Kenneth Anderson (1 shared filing) and Lusong Luo (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around James. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 6 bankruptcy cases matching the name listed in Key records below.
What this means 6 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for James Lu and found 5 differences: Form D filed 17 days after the first sale; Same name, different state: "James Lu" (F4) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.